A face-lift for biotech rules begins.

Emily Waltz, Nature Biotechnology (2015) 33:1221-1222. http://www.ncbi.nlm.nih.gov/pubmed/26650002

On October 3, 2015 the US government held the first of three public meetings to modernize federal regulations for genetically modified (GM) products.  The last time the regulations were updated was in 1986, and with the advent of new GM technologies such as CRISPR/Cas, the system is in strong need of updating.  Two of the main questions facing US federal agencies are: which agency is responsible for oversight, and should GM designation be based upon the end product or the process used.  Currently gene editing techniques, such as CRISPR, that do not add foreign DNA are not considered GM and thus not subject to the GM regulations.  Whether or not the definition of GM products will be expanded to include technologies such as CRISPR remains to be seen.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply